Muscle drives resting metabolism, insulin sensitivity, bone density, balance, and long-term weight maintenance
Studies report levels of approximately 200 ng/mL in a 20-year-old individual, compared to about 80 ng/mL at age 60
Tirzepatide was approved by the FDA for A1c lowering in Type 2 Diabetes in May 2022 Although it has not yet been approved for obesity, tirzepatide demonstrated significant weight reduction when analyzed as the secondary outcome in the SURPASS trials and as the primary outcome in the SURMOUNT I trial
To implement effective site rotation: Divide each injection area (abdomen, thigh, or arm) into sections Keep a simple record or mental note of which section was used for each weekly injection Move at least 23 cm away from the previous injection point Avoid returning to the same specific spot for several weeks Patients should inspect injection sites regularly for any signs of persistent redness, unusual lumps, or other changes
This study did not indicate a large increased risk of major congenital malformations in the babies born
GLP-1 levels often increase naturally after bariatric surgery